IDH2 and glioblastoma: Compared to IDH-mutant GBM cohorts, IDH-wildtype GBM had significantly more frequent instances of EGFR amplification, PTEN mutation, and TERTp mutation with significantly less frequent ATRX and TP53 mutations [4,6,43,44,52,90,107].